Traders Buy Large Volume of Cytokinetics Call Options (NASDAQ:CYTK)
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) was the target of unusually large options trading on Wednesday. Traders acquired 5,137 call options on the company. This is an increase of 96% compared to the typical daily volume of 2,622 call options. Insider Buying and Selling In other news, CEO Robert I. Blum sold 5,000 shares […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) was the target of unusually large options trading on Wednesday. Traders acquired 5,137 call options on the company. This is an increase of 96% compared to the typical daily volume of 2,622 call options. Insider Buying and Selling In other news, CEO Robert I. Blum sold 5,000 shares […]
